Matthew Smeds: Management of Thoracic Endograft Thrombosis and Mesenteric Embolization
Matthew Smeds, Professor of Vascular Surgery at Saint Louis University Vascular Surgery, shared a post on X:
”How should we manage thoracic endograft thrombosis when it occurs?
There’s little evidence and strategies range from anticoagulation to relining, bypass, or explantation.
In this case, recurrent thrombus plus mesenteric embolization was treated with redo TEVAR plus SMA thrombectomy.”
JVS-Cases Innovations and Techniques shared a post on X about a recent article by Yaima C. Valdes et al, published in Journal of Vascular Surgery: Cases and Innovative Techniques, adding:
”5 years after TEVAR, the thrombus came back.
This case of late thoracic endograft thrombosis with mesenteric embolization, without endoleak, migration, or identified hypercoagulability, raises questions about long-term surveillance.”
Title: Recurrent thoracic aortic stent graft thrombosis
Authors: Yaima C. Valdes, Faisal Khan, Thomas Abbruzzese
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 26, 2026, 16:04Isabelle Feldhaus: What the New ASH Iron Deficiency Guidance Means for Care
-
Sep 26, 2026, 15:55Francesca Palandri: The R-NAT Score Developed in Ruxolitinib-Treated MF Patients
-
Sep 26, 2026, 15:49Alex Ehsan: Antiphospholipid Syndrome – A Practical Guide
-
Sep 26, 2026, 15:42Michael Tadao Inouye: The Next Frontier in Genomic Population Health
-
Sep 26, 2026, 15:32Katariina Öörni: Familial Hypercholesterolaemia in Children Why Early Diagnosis Matters
-
Sep 26, 2026, 15:30P-Selectin as a Therapeutic Target in Thrombosis
-
Sep 26, 2026, 15:27Berkan Kurt: The Role of Biomarkers in Cardiovascular Prevention
-
Sep 26, 2026, 15:21Consuela A. Albright: Five Concrete Ways Steps to Advocate for Sickle Cell Disease
-
Sep 26, 2026, 15:09New ASH Funding Opportunities for Hematology Researchers